Search Results
Edit Save
429 results
Prostate Cancer INFOLINK 02/18/2019 12:31
In October 2018, the American Society of Radiation Oncologists (ASTRO) strongly endorsed moderately hypofractionated IMRT (20 or 28 treatments) for primary radiation treatment (see this link). Since then, there has been another publication of a randomized clinical trial with 10 years of follow-up (see this link). The advantages for the patient are large: fewer visits […]
Prostate Cancer INFOLINK 02/07/2019 08:18
It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. It has also long been suspected that African Americans may receive less aggressive treatment for prostate cancer than comparable white patients with […]
Prostate Cancer INFOLINK 02/01/2019 12:11
The Prostate Cancer Foundation (PCF) has just published the 2019 update to its Prostate Cancer Patient Guide, which is a very useful (and free) introduction to prostate cancer for patients and their caregivers. Newly updated information in the 2019 guide includes: The most recent USPSTF prostate cancer screening recommendations The management of patients on active […]
Prostate Cancer INFOLINK 01/30/2019 14:39
The results of a small, randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients already treated on intermittent androgen deprivation therapy (IADT) have recently been published. This trial was carried out by Choi et al. in Korean patients in South Korea. Their goal was to evaluate the anti-cancer activity of […]
Prostate Cancer INFOLINK 01/18/2019 10:10
The RESPOND study, which was initiated in July last year, appears to be the largest-ever study of risk factors for prostate cancer among the African American community, and probably among Black men worldwide. Prof. Christopher Haiman and his colleagues at the University of California, Los Angeles (UCLA), together with a team of researchers from 11 […]
Prostate Cancer INFOLINK 01/17/2019 09:21
For many years researchers have been trying to identify so-called “surrogate” endpoints that can be used to predict overall and prostate cancer-specific survival with high accuracy. The availability of such surrogate endpoints would permit us to significantly shorten the time it takes to carry out clinical trials for patients with advanced and high-risk forms of […]

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications